Back to results
US 2009/0312264 A1Published application
Squamous Cell Carcinoma Antigen-Derived Peptide Binding to HLA-A24 Molecule
AssigneeKurume University
InventorsKyogo Itoh, Mamoru Harada
Life of this patent
Estimating the term…
Abstract
Provided is a squamous cell carcinoma antigen derived peptide which is capable of binding to an HLA-A24 molecule and recognized by the cellular immune system, and a pharmaceutical composition comprising said peptide for the treatment or prevention of squamous cell carcinoma.
Claims12
A peptide, which is derived from squamous cell carcinoma antigen, capable of binding to an HLA-A24 molecule and recognized by the cellular immune system.
7-10. (canceled)
13-22. (canceled)
Dependencies are inferred from the claim text.